Ken Griffin Prefers Biotech to Large-Caps Like Apple & Priceline

We have gone through Citadel’s most recent 13F compared to the previous one (see a history of Citadel’s stock picks) and here’s what we noticed:

Biotech bets. The first thing to know about Citadel and Ken Griffin is that they typically employ a high level of portfolio turnover on a quarterly basis. Still, it’s worth tracking the moves they make, and a couple of the biggest new stakes they took last quarter were in Isis Pharma (NASDAQ:ISIS) and Elan Corporation, plc (ADR) (NYSE:ELN). Isis is a small-cap therapeutics company that seeks to develop RNA-based drugs, while Elan is larger, and has its fingers in drugs that treat autoimmune and neurodegenerative diseases. Both are absolutely booming year-to-date, with Elan up 75% and Isis up 200%, but judging by Citadel’s history of growth-related stock picks, we’re not surprised. Both biotech players are fairly valued and analysts expect the growth to continue; if 2014 is a good year for healthcare, Griffin may be well-positioned here.

Ken Griffin with computers

Non-cyclical consumer goods. In the non-cyclicals, meanwhile, Griffin and Citadel were boosting their stakes in Safeway Inc. (NYSE:SWY) and Philip Morris International Inc. (NYSE:PM). Like most of the hedge fund’s other buys, both stocks currently have market sentiment on their side. Safeway is currently in the process of exploring a sale of its U.S. business, with most estimates placing a fair deal value between $40 and $45 a share (it currently trades near $34).

Philip Morris, on the other hand, is a more traditional bet on a tobacco industry that is set to gain from emerging markets in the future. Philip Morris in particular has an enormous potential to expand in Asian countries like China and India, perhaps even more so than most of its closest competitors. With gross margins up by about 1 percentage point since 2009 on the back of a fairly large cost-cutting program, profitability is also healthier than it’s been in a decade.

Large-cap growth. Interestingly, Griffin and Citadel were cutting their positions in large-cap growth companies like Apple Inc. (NASDAQ:AAPL) and Priceline.com Inc (NASDAQ:PCLN). The latter has had a better 2013 than Apple and now trades above the $1,000 mark, but valuation concerns persist. Apple, meanwhile, is still a growth company by our standards, and it’s somewhat curious Griffin trimmed his stake by 45% here. We’ll be watching closely next quarter.

A couple notable sales. Lastly, the billionaire also sold out of Hertz Global Holdings, Inc. (NYSE:HTZ) and AutoZone, Inc. (NYSE:AZO) entirely, and both the car rental giant and the auto servicer have been kind to him. The valuation isn’t scary at either stock, and long-term growth prospects are still their, but both have outperformed the market of late, so it’s possible Griffin decided to cash in his gains while the getting was good, for lack of a better phrase.

Disclosure: none

Recommended Reading:

Leon Cooperman Trades Wells Fargo For Citi, Bets On Rebound In Gas & Gold

Paul Singer Prefers Twenty-First Century Fox to News Corp By An 8:1 Ratio

Bill Ackman Takes Profits At General Growth and P&G

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!